← Leaderboards
Pamela Harding
Henry Ford Health System
$4,117,096
Attributed
$4,117,096
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $623.2K · FY2011–23$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,117,096 · 3
By mechanism
R01$2,226,315 · 1
P01$1,890,781 · 2
Top collaborators
No co-investigators on record.
Most similar at Henry Ford Health System
Same institution · by research overlap
- Oscar A. Carretero$13,917,720
- Gustavo R Ares-Sarmiento$741,415
- Edward G. Shesely$3,428,437
- David E Lanfear$7,880,808
- Margot Claire Lapointe$974,680
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventEventReceptorInflammationAdultAngiotensin IiMouse ModelProstaglandinsHeartHypertensionHeart FailureMyocardial InfarctionCoupledCardiac MyocytesDinoprostoneEp4 ReceptorCardiacCardiovascular DiseasesMorbidity - Disease RateIn VivoMediatingPathogenesisCause Of DeathAgonist
Grant awards (11)
Opposing Effects of Prostaglandin E2 EP3 and EP4 Receptors on Mitochondrial$546,175
R01 · FY2023 · HL · contact PI
Administrative Supplement to 7R01HL148060-03 Titled: Opposing Effects of Prostaglandin E2 EP3 and EP4 Receptors on Mitochondrial$77,000
R01 · FY2023 · HL · contact PI
Opposing Effects of Prostaglandin E2 EP3 and EP4 Receptors on Mitochondrial$537,397
R01 · FY2022 · HL · contact PI
Opposing Effects of Prostaglandin E2 EP3 and EP4 Receptors on Mitochondrial$537,398
R01 · FY2021 · HL · contact PI
Opposing Effects of Prostaglandin E2 EP3 and EP4 Receptors on Mitochondrial Function in the Failing Heart$528,345
R01 · FY2020 · HL · contact PI
Hypertensive End Organ Damage: Protective Role of PGE2 and EP4 Receptor$331,192
P01 · FY2017 · HL · contact PI
Hypertensive End Organ Damage: Protective Role of PGE2 and EP4 Receptor$331,191
P01 · FY2016 · HL · contact PI
Hypertensive End Organ Damage: Protective Role of PGE2 and EP4 Receptor$326,555
P01 · FY2015 · HL · contact PI
Hypertensive End Organ Damage: Protective Role of PGE2 and EP4 Receptor$326,981
P01 · FY2014 · HL · contact PI
Hypertensive End Organ Damage: Protective Role of PGE2 and EP4 Receptor$331,192
P01 · FY2013 · HL · contact PI
Ang II-Induced Hypertension: Role of PGE2 and EP4 in End Organ Damage$243,670
P01 · FY2011 · HL · contact PI